With demand rising for GLP-1 medications like Wegovy™ (semaglutide) and Mounjaro™ (tirzepatide), the NHS, with its limited budget and system limitations, is finding it increasingly difficult to keep up. This has created an unfortunate situation, where people who are eligible for the breakthrough medication is unable to get access to it.

If you can't afford to wait for the NHS to catch up with the demand, Embla offers a quicker solution.

Get faster access to weight loss medication through Embla

At Embla, we understand that getting help sooner rather than later is essential. Because of this, we offer GLP-1 medications like Wegovy and Mounjaro without the long delays that come with NHS processes. Being a private weight loss service with various partnerships, we're able to process appointments and deliveries faster, which means you can start treatment without having to wait months.

To find out if you're eligible for treatment, complete our sign up process.

NHS delays will continue

Recently, the NHS began a phased rollout of Mounjaro to ease the burden on healthcare providers. While this helps in the long term, it also means that the delays aren't expected to clear up any time soon.

How to get started with Embla

If getting access to these proven GLP-1 medications is a priority for you, Embla is a quick, reliable provider. Our comprehensive study-backed coaching program also ensures that you get the support to make your results last and safely come off the medication once you reach your goals.

To get started, go here.